Please login to the form below

From promise to practice: immuno-oncology in action Part 3 - Emerging Markets

Our latest white paper on immuno-oncology explores the challenges and opportunities in emerging markets, with a focus on Asia.

This is the final part in the series where we interviewed key opinion leader physicians and payers to explore how new oncology products are likely to fare clinically and financially. In Part 1 we looked at the current situation in the US and in part 2 we explored how the situation is developing in the EU. 

Download parts 1, 2 and 3: http://www.researchpartnership.com/news/2015/11/free-thinking-from-promise-to-practice-immuno-oncolo...


16th May 2016

Share

Tags

Company Details

Research Partnership

+44 (0)20 8069 5000

Contact Website

Address:
Chester House
Fulham Green
81-83 Fulham High Street
London
SW6 3JW
United Kingdom

Latest content on this profile

Live webinar: Optimise your digital assets with UX research
Thursday 25th October 2018 11:00 EDT / 16:00 BST / 17:00 CEST
Research Partnership
Rare diseases and orphan drugs: Our experience and expertise

Research Partnership
Conducting research for publication video

Research Partnership
Conference research case study
How conference research was used to gauge reactions to new clinical data and measure the impact of a company’s presence at a leading industry event
Research Partnership
Portfolio analysis: Using market research to master communications across a therapeutic category

Research Partnership
EphMRA round up 2018
EU Directors Angela Duffy, Richard Head and Dan coffin attended the EphMRA annual conference in Basel.
Research Partnership